Investec Bank Plc has filed a Form 8.5 regulatory disclosure relating to share dealings in Advanced Medical Solutions Group Plc (AMS.L) on September 9, 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank Plc is identified in the filing as advisor and joint broker to Advanced Medical Solutions Group Plc, establishing its connected status to the offer.
The bank filed the disclosure in its capacity as an exempt principal trader dealing in a client-serving capacity, as required under the Takeover Code framework.
On September 9, 2026, Investec Bank Plc purchased a total of 240,944 ordinary shares in Advanced Medical Solutions Group Plc during its client-serving dealings.
The purchases were executed at prices ranging from a low of 280.75 pence per unit to a high of 281.25 pence per unit during the trading session.
In addition to the purchases, Investec Bank Plc also recorded sales of 172,918 ordinary shares in Advanced Medical Solutions Group Plc on the same date.
The sales were completed at prices ranging from 280.5 pence to 281.25 pence per unit, reflecting tight pricing conditions across the session.
The filing confirms there were no cash-settled derivative transactions, stock-settled derivative transactions, or other dealings such as subscriptions or conversions undertaken on that date.
Investec also confirmed that no indemnity arrangements, option agreements, or understandings relating to voting rights or future acquisition of relevant securities were in place in connection with this disclosure.
The contact named in the filing is Abhishek Gawde, with the disclosure dated September 10, 2026, the day following the dealing date.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service to ensure market transparency.
